✦ LIBER ✦

Beta-adrenergic blockers in mental retardation and developmental disabilities

✍ Scribed by Ruedrich, Stephen ;Erhardt, Lendita

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 149 KB
Volume: 5
Category: Article
ISSN: 1080-4013
DOI: 10.1002/(sici)1098-2779(1999)5:4<290::aid-mrdd6>3.0.co;2-6

No coin nor oath required. For personal study only.

✦ Synopsis

Beta-adrenergic-blocking medications have been hypothesized to benefit persons with a wide variety of neuropsychiatric disorders. Research supports their use in only three areas, however: anxiety disorders with prominent physiological signs, impulsive aggression, and neuroleptic-induced akathisia (NIA). Except for NIA, beta blockers are best used adjunctively, and cannot be considered treatments of choice as monotherapy. These guidelines are applicable to individuals with intellectual disability and psychiatric illness as well, and beta blockers are generally effective and well tolerated in these persons. Nadolol, a hydrophilic beta blocker, may be preferable for anxiety, whereas propranolol and metoprolol (lipophilic) are more beneficial in treating aggression and NIA.

📜 SIMILAR VOLUMES

Overview: Psychopharmacology in mental r

Overview: Psychopharmacology in mental retardation and developmental disabilities

✍ Schroeder, Stephen R. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

Drug-behavior interactions in persons wi

Drug-behavior interactions in persons with mental retardation and developmental disabilities

✍ Napolitano, Deborah A. ;Jack, Susan L. ;Sheldon, Jan B. ;Williams, Dean C. ;McAd 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Treatment for aberrant behavior in persons diagnosed with developmental disabilities typically involves either behavioral interventions or medication. Often, the treatment is a combination of the two. Schroeder and coworkers Adv Learn Behav Disabil 2:179-225) outlined criteria for the evaluation of

Theoretical perspectives on language and

Theoretical perspectives on language and communication problems in mental retardation and developmental disabilities

✍ Abbeduto, Leonard ;Evans, Julia ;Dolan, Terrence 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Risks for severe mental retardation occu

Risks for severe mental retardation occurring in isolation and with other developmental disabilities

✍ Laura L. Jelliffe-Pawlowski; Gary M. Shaw; Verne Nelson; John A. Harris 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

Nutritional, dietary, and hormonal treat

Nutritional, dietary, and hormonal treatments for individuals with mental retardation and developmental disabilities

✍ Ellis, Cynthia R. ;Singh, Nirbhay N. ;Ruane, Amy L. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Nutritional, dietary, and hormonal approaches to producing behavioral, emotional, and cognitive changes in individuals with mental retardation and developmental disabilities (MRDD) flourished in the 1970s and 1980s. Although an occasional article is still published, there was little serious research

Measuring side effects of psychopharmaco

Measuring side effects of psychopharmacologic medication in individuals with mental retardation and developmental disabilities

✍ Kalachnik, John E. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

To various degrees, psychopharmacologic medications are associated with side effects. Despite improvements in newer psychopharmacologic medication, monitoring for side effects remains important for individuals with mental retardation and developmental disabilities for a number of reasons, of which p